{
  "denotations": [
    {
      "id": "T1",
      "obj": "Disease",
      "span": {
        "begin": 13,
        "end": 26
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 59,
        "end": 65
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 135,
        "end": 144
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 96,
        "end": 105
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "26369533_2",
  "text": "UNASSIGNED : Breast cancer patients with absent or reduced CYP2D6 activity and consequently low endoxifen levels may benefit less from tamoxifen treatment ."
}
